Patents Examined by Young J. Kim
  • Patent number: 10648025
    Abstract: Provided herein is technology relating to the amplification-based detection of bisulfite-treated DNAs and particularly, but not exclusively, to methods and compositions for multiplex amplification of low-level sample DNA prior to further characterization of the sample DNA. The technology further provides methods for isolating DNA from blood or blood product samples, e.g., plasma samples.
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: May 12, 2020
    Assignee: EXACT SCIENCES DEVELOPMENT COMPANY, LLC
    Inventors: Hatim T. Allawi, William G. Weisburg, Graham P. Lidgard, Michael W. Kaiser, Abram M. Vaccaro, Gracie Shea
  • Patent number: 10648037
    Abstract: The present invention discloses a method for non-invasively detecting EGFR gene mutations in subjects, comprising the following steps: designing primers according to EGFR gene exons; extracting plasma DNAs in subjects; connecting the extracted plasma DNAs with tagging linkers; PCR pre-amplifying the tagging linkers connected plasma DNAs; cyclising the pre-amplified DNAs to obtain cyclised DNAs; PCR amplifying the cyclised DNAs using the designed primers; and high throughput sequencing the PCR amplified product and analyzing the EGFR gene mutations. The present invention also discloses a corresponding kit.
    Type: Grant
    Filed: December 16, 2014
    Date of Patent: May 12, 2020
    Assignee: Berry Genomics Co., Ltd.
    Inventors: Lina Wang, Lanlan Ru, Tiancheng Li, Yaxi Zhang, Jianguang Zhang
  • Patent number: 10640764
    Abstract: There is disclosed a process for in vitro synthesis and assembly of long, gene-length polynucleotides based upon assembly of multiple shorter oligonucleotides synthesized in situ on a microarray platform. Specifically, there is disclosed a process for in situ synthesis of oligonucleotide fragments on a solid phase microarray platform and subsequent, “on device” assembly of larger polynucleotides composed of a plurality of shorter oligonucleotide fragments.
    Type: Grant
    Filed: February 23, 2017
    Date of Patent: May 5, 2020
    Assignee: Gen9, Inc.
    Inventor: Andrew V. Oleinikov
  • Patent number: 10639597
    Abstract: The present invention provides novel microfluidic substrates and methods that are useful for performing biological, chemical and diagnostic assays. The substrates can include a plurality of electrically addressable, channel bearing fluidic modules integrally arranged such that a continuous channel is provided for flow of immiscible fluids.
    Type: Grant
    Filed: February 1, 2018
    Date of Patent: May 5, 2020
    Assignee: Bio-Rad Laboratories, Inc.
    Inventors: Darren Roy Link, Michael Weiner, David Marran, Jonathan M. Rothberg
  • Patent number: 10625220
    Abstract: The present invention provides novel microfluidic substrates and methods that are useful for performing biological, chemical and diagnostic assays. The substrates can include a plurality of electrically addressable, channel bearing fluidic modules integrally arranged such that a continuous channel is provided for flow of immiscible fluids.
    Type: Grant
    Filed: June 1, 2018
    Date of Patent: April 21, 2020
    Assignee: Bio-Rad Laboratories, Inc.
    Inventors: Darren Roy Link, Michael Weiner, David Marran, Jonathan M. Rothberg
  • Patent number: 10619190
    Abstract: The present invention provides methods, compositions, kits, systems and apparatus that are useful for isolating nucleic acid molecules from a sample. In particular, the methods generally relate to normalizing the concentration of target nucleic acid molecules from a sample. In one aspect, the invention relates to purifying a primer extension product from a primer extension reaction mixture. In some aspects, nucleic acid molecules obtained using the disclosed methods, kits, systems and apparatuses can be used in various downstream processes including nucleic acid sequencing.
    Type: Grant
    Filed: April 19, 2018
    Date of Patent: April 14, 2020
    Assignee: Life Technologies Corporation
    Inventors: Mark Andersen, Steven Roman
  • Patent number: 10604791
    Abstract: Provided herein are products and processes for detecting the presence or absence of multiple target nucleic acids. Certain methods include amplifying the target nucleic acids, or portion thereof; extending oligonucleotides that specifically hybridize to the amplicons, where the extended oligonucleotides include a capture agent; capturing the extended oligonucleotides to a solid phase via the capture agent; releasing the extended oligonucleotide by competition with a competitor; detecting the extended oligonucleotide, and thereby determining the presence or absence of each target nucleic acid by the presence or absence of the extended oligonucleotide.
    Type: Grant
    Filed: July 17, 2012
    Date of Patent: March 31, 2020
    Assignee: Agena Bioscience, Inc.
    Inventors: Christiane Honisch, Dirk Johannes Van Den Boom, Michael Mosko, Anders Nygren
  • Patent number: 10604794
    Abstract: The present disclosure encompasses methods and compositions for analyzing telomeres of genomic DNA, including the length of one or more telomeres. In specific embodiments, methods and compositions are employed for identification of the length of the shortest telomere in a collection of genomic DNA. In particular cases, the method greatly suppresses amplification of intra-genomic DNA fragments in comparison to telomeres by hindering their amplification using particular adaptors.
    Type: Grant
    Filed: May 10, 2018
    Date of Patent: March 31, 2020
    Assignee: The Board of Regents of the University of Texas System
    Inventors: Jerry W. Shay, Tsung-Po Lai
  • Patent number: 10604800
    Abstract: The present invention provides methods of increasing sequencing accuracy. For example, the methods of the invention use linear amplification to generate a relatively small population of template molecules that may be subsequently amplified into a larger clonal population of DNA molecules for sequencing.
    Type: Grant
    Filed: June 12, 2015
    Date of Patent: March 31, 2020
    Assignee: Illumina Cambridge Limited
    Inventors: Roberto Rigatti, Jonathan Mark Boutell
  • Patent number: 10597714
    Abstract: Provided herein are methods and apparatus for the identification of pathogenic and non-pathogenic microorganisms in food and environmental samples. The disclosure solves existing challenges encountered in identifying food borne pathogens, including pathogens of the Salmonella, Campylobacter, Listeria, and Escherichia genera in a timely and efficient manner. The disclosure also provides methods for differentiating a transient versus a resident pathogen, correlating presence of non-pathogenic with pathogenic microorganisms, distinguishing live versus dead microorganisms by sequencing.
    Type: Grant
    Filed: January 30, 2019
    Date of Patent: March 24, 2020
    Assignee: Clear Labs, Inc.
    Inventors: Sasan Amini, Ramin Khaksar, Michael Taylor, Shadi Shokralla, Christopher Haney, Pavan Vaidyanathan, Adam Allred, David Tran, Hossein Namazi, Julius Barsi
  • Patent number: 10597699
    Abstract: The present invention provides a method for generating an amplified nucleic acid portion of a template RNA molecule, comprising after having obtained a template RNA, annealing a first oligonucleotide primer at a preselected 3? terminal nucleic acid region of the template RNA, elongating the first oligonucleotide primer in a template specific manner thereby obtaining a first elongated strand, removing the RNA template, annealing one or more further oligonucleotide primers to the first elongated strand, elongating the one or more further oligonucleotide primers in a template specific manner without strand displacement of polynucleotides annealed to the first elongated strand or using a polymerase that destroys a displaced strand, thereby generating further elongation products, isolating and/or amplifying an elongation product of said further elongation product comprising a nucleic acid portion that is elongated complementary to the first oligonucleotide primer; as well as kits for performing the method.
    Type: Grant
    Filed: March 20, 2015
    Date of Patent: March 24, 2020
    Assignee: LEXOGEN GMBH
    Inventor: Pamela Moll
  • Patent number: 10590453
    Abstract: The present invention provides methods of amplifying a target nucleic acid utilizing a circularized template. Circularization may be achieved utilizing a bridging oligonucleotide or an inverter primer. The bridging oligonucleotide or inverted primer is extended forming a concatemeric amplicon that can then be used as a template to provide exponential amplification of the target nucleic acid.
    Type: Grant
    Filed: August 16, 2018
    Date of Patent: March 17, 2020
    Assignee: AEGEA BIOTECHNOLOGIES, INC.
    Inventors: Lyle J. Arnold, Norman C. Nelson
  • Patent number: 10590464
    Abstract: Presented herein are methods and compositions for enhancing utilization of surface primers during the surface amplification process. The methods are useful for surface amplification at improved densities. The methods and compositions provided herein enable creation of clusters which are brighter, but at the same densities as currently achieved using standard cluster amplification.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: March 17, 2020
    Assignee: Illumina Cambridge Limited
    Inventors: Jonathan Mark Boutell, Gary Mark Skinner
  • Patent number: 10584332
    Abstract: The invention provides barcode libraries and methods of making and using them including obtaining a plurality of nucleic acid constructs in which each construct comprises a unique N-mer and a functional N-mer and segregating the constructs into a fluid compartments such that each compartment contains one or more copies of a unique construct. The invention further provides methods for digital PCR and for use of barcode libraries in digital PCR.
    Type: Grant
    Filed: January 14, 2016
    Date of Patent: March 10, 2020
    Assignee: Bio-Rad Laboratories, Inc.
    Inventors: Michael L. Samuels, Jeffrey Charles Olson, Andrew Watson, Keith Brown, Darren R. Link
  • Patent number: 10584390
    Abstract: The present invention provides quantitative polymerase chain reaction (PCR) methods and kits for diagnosing trichomoniasis.
    Type: Grant
    Filed: August 6, 2015
    Date of Patent: March 10, 2020
    Assignee: THE TEXAS A&M UNIVERSITY SYSTEM
    Inventors: Mangkey A. Bounpheng, Thomas B. Hairgrove, Carly C. Summarell, Megan E. Schroeder
  • Patent number: 10563256
    Abstract: The invention relates to methods for pairwise sequencing of a double stranded polynucleotide template, which permit the sequential determination of nucleotide sequences in two distinct and separate regions on complementary strands of the double-stranded polynucleotide template. The two regions for sequence determination may or may not be complementary to each other.
    Type: Grant
    Filed: May 1, 2017
    Date of Patent: February 18, 2020
    Assignee: Illumina Cambridge Limited
    Inventor: Geoffrey Paul Smith
  • Patent number: 10557174
    Abstract: Methods and systems for quantification of a target nucleic acid in a sample are provided. The method includes forming a plurality of discrete sample portions. Each of the plurality of discrete sample portions comprising a portion of the sample, and a reaction mixture. The method further includes amplifying the plurality of discrete sample portions to form a plurality of discrete processed sample portions. At least one discrete processed sample portion containing nucleic acid amplification reaction products. Fluorescence signals are detected from the at least one of the plurality of discrete processed sample portions to determine a presence of the at least one target nucleic acid. The method also includes determining the respective volumes of the plurality of the plurality of discrete processed sample portions, and estimating the number of copies-per-unit-volume of the at least one target nucleic acid in the sample.
    Type: Grant
    Filed: March 25, 2016
    Date of Patent: February 11, 2020
    Assignee: Life Technologies Corporation
    Inventors: Gordon A. Janaway, Mark Andersen, Kornelija Zgonc, Michael C. Pallas, Marcin Sikora, Casey R. McFarland, Ferrier N. Le, Haopeng Wang, Jian Gong, Gothami Padmabandu
  • Patent number: 10557164
    Abstract: Provided herein are compositions and methods for analysis of nucleic acids, including, methods and compositions for genotyping, haplotyping, sequencing and performing other genetic and epigenetic analyses on nucleic acids, for example. In some embodiments, methods and compositions suitable for whole-genome sequencing on single molecules of nucleic acid are provided. In some embodiments, analysis of single molecules of nucleic acid are performed in conjunction with nanopores and/or nanopore devices.
    Type: Grant
    Filed: September 17, 2014
    Date of Patent: February 11, 2020
    Assignee: Sequenom, Inc.
    Inventor: Charles R. Cantor
  • Patent number: 10538795
    Abstract: The present invention relates to methods for generating a labelled nucleic acid from an RNA comprising a 5? protecting group, said method comprises the steps of obtaining a mixture of template strands of nucleic acids, said mixture comprising said RNA and further potentially other nucleic acids without a 5? protecting group, annealing at least one oligonucleotide primer to the template strand of said RNA and potentially other nucleic acids, and template sequence dependent extending said primer, thereby obtaining a complementary nucleic acid strand annealed to its template strand, or providing the RNA in duplex with a complementary nucleic acid strand annealed to its template strand, and optionally modifying the extension product of said nucleic acids without 5? protecting group either on the 5? end of the template strand or on the 3? end of the complementary strand, or both, and labelling a complementary nucleic acid of a double stranded nucleic acid not modified, wherein therefore the labelled nucleic acid d
    Type: Grant
    Filed: July 10, 2013
    Date of Patent: January 21, 2020
    Assignee: LEXOGEN GMBH
    Inventors: Alexander Seitz, Irmlind Gabler, Lukas Paul
  • Patent number: 10519488
    Abstract: Described herein, among other things, is a method of sequencing, comprising: concatenating a plurality of fragments of genomic DNA to produce concatenated DNA; sequencing the concatenated DNA to produce a plurality of sequence reads, wherein at least some of the sequence reads comprise: at least the sequence of the 3? and/or 5? ends of a fragment that corresponds to the locus of interest and sequence of one or both of the fragments that flank the fragment in the concatenated DNA; and grouping the sequence reads that corresponds to the locus of interest using, for each of the grouped sequence reads: the 3? and/or 5? end sequences; and/or the flanking sequence.
    Type: Grant
    Filed: September 1, 2016
    Date of Patent: December 31, 2019
    Assignee: OXFORD NANOPORE TECHNOLOGIES, LTD.
    Inventors: Robert Osborne, Esther Musgrave-Brown